Multistage Carcinogenesis

Cell and Animal Models

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Carcinogenesis is a multistage process that involves numerous etiologies that work at different stages. Our ability to dissect oncogenic events is largely dependent on the availability of model systems that recapitulate human carcinogenesis at pathological and molecular levels. With the progress in molecular and cell biology, studies with cell model systems have produced many important conceptual advances for our understanding of the mechanism of carcinogenesis. In parallel, animal models are required to provide the tissue and the systemic contexts of carcinogenesis and to validate molecular predictions and targeting opportunities in cancer prevention and treatment. With the development of genetically engineered mouse models, it is possible to define the function and dynamics of genetic alterations at discrete steps in carcinogenesis. The cooperative models that bridge cell culture and corresponding animal sites offer simple and quantitative approaches to evaluate the oncogenic potential of carcinogens (chemical, viral, and physical agents) as well as the roles of discrete candidate cancer genes in carcinogenesis. The choice of a model is of importance and should take into account the cell/tissue type of origin, the complexity of carcinogenesis, the variety of carcinogen and therapeutic reagents to be tested, and the relevance to human cancer.

Original languageEnglish (US)
Title of host publicationCarcinogenesis
PublisherElsevier Inc.
Pages11-33
Number of pages23
Volume14
ISBN (Print)9780080468686
DOIs
StatePublished - Aug 12 2010

Fingerprint

Carcinogenesis
Animal Models
Carcinogens
Neoplasm Genes
Cell Biology
Molecular Biology
Neoplasms
Cell Culture Techniques
Therapeutics

Keywords

  • Animal model
  • Carcinogenesis
  • Cell model
  • Tumor promotion

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Multistage Carcinogenesis : Cell and Animal Models. / Kulesz-Martin, Molly; Gallegos, J. R.; Liu, Yuangang.

Carcinogenesis. Vol. 14 Elsevier Inc., 2010. p. 11-33.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kulesz-Martin, Molly ; Gallegos, J. R. ; Liu, Yuangang. / Multistage Carcinogenesis : Cell and Animal Models. Carcinogenesis. Vol. 14 Elsevier Inc., 2010. pp. 11-33
@inbook{11df0f5eb5df4be095794746979f3fed,
title = "Multistage Carcinogenesis: Cell and Animal Models",
abstract = "Carcinogenesis is a multistage process that involves numerous etiologies that work at different stages. Our ability to dissect oncogenic events is largely dependent on the availability of model systems that recapitulate human carcinogenesis at pathological and molecular levels. With the progress in molecular and cell biology, studies with cell model systems have produced many important conceptual advances for our understanding of the mechanism of carcinogenesis. In parallel, animal models are required to provide the tissue and the systemic contexts of carcinogenesis and to validate molecular predictions and targeting opportunities in cancer prevention and treatment. With the development of genetically engineered mouse models, it is possible to define the function and dynamics of genetic alterations at discrete steps in carcinogenesis. The cooperative models that bridge cell culture and corresponding animal sites offer simple and quantitative approaches to evaluate the oncogenic potential of carcinogens (chemical, viral, and physical agents) as well as the roles of discrete candidate cancer genes in carcinogenesis. The choice of a model is of importance and should take into account the cell/tissue type of origin, the complexity of carcinogenesis, the variety of carcinogen and therapeutic reagents to be tested, and the relevance to human cancer.",
keywords = "Animal model, Carcinogenesis, Cell model, Tumor promotion",
author = "Molly Kulesz-Martin and Gallegos, {J. R.} and Yuangang Liu",
year = "2010",
month = "8",
day = "12",
doi = "10.1016/B978-0-08-046884-6.01402-0",
language = "English (US)",
isbn = "9780080468686",
volume = "14",
pages = "11--33",
booktitle = "Carcinogenesis",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Multistage Carcinogenesis

T2 - Cell and Animal Models

AU - Kulesz-Martin, Molly

AU - Gallegos, J. R.

AU - Liu, Yuangang

PY - 2010/8/12

Y1 - 2010/8/12

N2 - Carcinogenesis is a multistage process that involves numerous etiologies that work at different stages. Our ability to dissect oncogenic events is largely dependent on the availability of model systems that recapitulate human carcinogenesis at pathological and molecular levels. With the progress in molecular and cell biology, studies with cell model systems have produced many important conceptual advances for our understanding of the mechanism of carcinogenesis. In parallel, animal models are required to provide the tissue and the systemic contexts of carcinogenesis and to validate molecular predictions and targeting opportunities in cancer prevention and treatment. With the development of genetically engineered mouse models, it is possible to define the function and dynamics of genetic alterations at discrete steps in carcinogenesis. The cooperative models that bridge cell culture and corresponding animal sites offer simple and quantitative approaches to evaluate the oncogenic potential of carcinogens (chemical, viral, and physical agents) as well as the roles of discrete candidate cancer genes in carcinogenesis. The choice of a model is of importance and should take into account the cell/tissue type of origin, the complexity of carcinogenesis, the variety of carcinogen and therapeutic reagents to be tested, and the relevance to human cancer.

AB - Carcinogenesis is a multistage process that involves numerous etiologies that work at different stages. Our ability to dissect oncogenic events is largely dependent on the availability of model systems that recapitulate human carcinogenesis at pathological and molecular levels. With the progress in molecular and cell biology, studies with cell model systems have produced many important conceptual advances for our understanding of the mechanism of carcinogenesis. In parallel, animal models are required to provide the tissue and the systemic contexts of carcinogenesis and to validate molecular predictions and targeting opportunities in cancer prevention and treatment. With the development of genetically engineered mouse models, it is possible to define the function and dynamics of genetic alterations at discrete steps in carcinogenesis. The cooperative models that bridge cell culture and corresponding animal sites offer simple and quantitative approaches to evaluate the oncogenic potential of carcinogens (chemical, viral, and physical agents) as well as the roles of discrete candidate cancer genes in carcinogenesis. The choice of a model is of importance and should take into account the cell/tissue type of origin, the complexity of carcinogenesis, the variety of carcinogen and therapeutic reagents to be tested, and the relevance to human cancer.

KW - Animal model

KW - Carcinogenesis

KW - Cell model

KW - Tumor promotion

UR - http://www.scopus.com/inward/record.url?scp=85012847611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012847611&partnerID=8YFLogxK

U2 - 10.1016/B978-0-08-046884-6.01402-0

DO - 10.1016/B978-0-08-046884-6.01402-0

M3 - Chapter

SN - 9780080468686

VL - 14

SP - 11

EP - 33

BT - Carcinogenesis

PB - Elsevier Inc.

ER -